Shanghai Medicilon Inc
SSE:688202
Shanghai Medicilon Inc
Cash from Financing Activities
Shanghai Medicilon Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Medicilon Inc
SSE:688202
|
Cash from Financing Activities
¥108.9m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Financing Activities
¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Financing Activities
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Financing Activities
-¥7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash from Financing Activities
¥3.3B
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Medicilon Inc's Cash from Financing Activities?
Cash from Financing Activities
108.9m
CNY
Based on the financial report for Dec 31, 2022, Shanghai Medicilon Inc's Cash from Financing Activities amounts to 108.9m CNY.
What is Shanghai Medicilon Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-43%
The average annual Cash from Financing Activities growth rates for Shanghai Medicilon Inc have been -43% over the past three years .